Optimizing remote treatment for obesity
Evaluating the EVO Treatment Optimized for Resource Constraints: Elements Vital to Treat Obesity.
NA · Northwestern University · NCT04708769
This study is testing a new mobile health program for weight loss against a standard diabetes prevention program to see which one helps people lose weight better over six months.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 524 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Northwestern University (other) |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT04708769 on ClinicalTrials.gov |
What this trial studies
This study evaluates a newly optimized mobile health intervention for obesity against the established Diabetes Prevention Program (DPP) in a randomized controlled trial. Participants will be assigned to either the APP, which utilizes a smartphone application for self-monitoring and biweekly sessions with a Health Promotionist, or the DPP, which involves guided sessions and participant logs for tracking weight and activity. The study aims to assess weight-loss success and cost-effectiveness over a 24-week intervention period, with follow-up assessments at 3, 6, and 12 months.
Who should consider this trial
Good fit: Ideal candidates are adults with a BMI between 30 and 45 who are stable in weight and own a smartphone.
Not a fit: Patients currently enrolled in formal weight loss programs or those with certain medical conditions, such as diabetes requiring insulin, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective and accessible method for managing obesity through mobile health technology.
How similar studies have performed: Other studies have shown promise in using mobile health interventions for weight management, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI 30-45 * Weight stable * Own a Smartphone and be willing to install our Smartphone app * Willing to conduct video conference calls with study staff Exclusion Criteria: * Enrolled in any formal weight loss program * Taking anti-obesity medications * Not taking medications that may cause weight gain * Unstable medical conditions * Diabetes requiring insulin supplementation * Crohn's Disease * Diagnosis of obstructive sleep apnea requiring intervention (i.e., CPAP) * Assistive devices for mobility * Hospitalizations for a psychiatric disorder within the past 5 years * Cardiovascular disease symptoms while performing moderate intensity exercise * Pregnancy, trying to get pregnant, or lactating. * Bulimia or binge eating disorder * Reports of active suicidal ideation * Current substance abuse or dependence besides nicotine dependence
Where this trial is running
Chicago, Illinois
- Northwestern University — Chicago, Illinois, United States (RECRUITING)
Study contacts
- Principal investigator: Angela Pfammatter, PhD — Northwestern University
- Study coordinator: Angela Pfammatter, PhD
- Email: angela@northwestern.edu
- Phone: 865-974-9126
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Obesity, Weight Loss, Diet, Physical Activity, Self Monitoring, Mobile Health